Anal Carcinoma, version 2.2018 clinical practice guidelines in Oncology

Al B. Benson, Alan P. Venook, Mahmoud M. Al-Hawary, Lynette Cederquist, Yi Jen Chen, Kristen K. Ciombor, Stacey Cohen, Harry S. Cooper, Dustin Deming, Paul F. Engstrom, Jean L Grem, Axel Grothey, Howard S. Hochster, Sarah Hoffe, Steven Hunt, Ahmed Kamel, Natalie Kirilcuk, Smitha Krishnamurthi, Wells A. Messersmith, Jeffrey MeyerhardtMary F. Mulcahy, James D. Murphy, Steven Nurkin, Leonard Saltz, Sunil Sharma, David Shibata, John M. Skibber, Constantinos T. Sofocleous, Elena M. Stoffel, Eden Stotsky-Himelfarb, Christopher G. Willett, Evan Wuthrick, Kristina M. Gregory, Deborah A. Freedman-Cass

Research output: Contribution to journalReview article

17 Citations (Scopus)

Abstract

The NCCN Guidelines for Anal Carcinoma provide recommendations for the management of patients with squamous cell carcinoma of the anal canal or perianal region. Primary treatment of anal cancer usually includes chemoradiation, although certain lesions can be treated with margin-negative local excision alone. Disease surveillance is recommended for all patients with anal carcinoma because additional curative-intent treatment is possible. A multidisciplinary approach including physicians from gastroenterology, medical oncology, surgical oncology, radiation oncology, and radiology is essential for optimal patient care.

Original languageEnglish (US)
Pages (from-to)852-871
Number of pages20
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume16
Issue number7
DOIs
StatePublished - Jul 1 2018

Fingerprint

Practice Guidelines
Anus Neoplasms
Carcinoma
Radiation Oncology
Medical Oncology
Anal Canal
Gastroenterology
Radiology
Squamous Cell Carcinoma
Patient Care
Guidelines
Physicians
Therapeutics
Surgical Oncology

ASJC Scopus subject areas

  • Oncology

Cite this

Benson, A. B., Venook, A. P., Al-Hawary, M. M., Cederquist, L., Chen, Y. J., Ciombor, K. K., ... Freedman-Cass, D. A. (2018). Anal Carcinoma, version 2.2018 clinical practice guidelines in Oncology. JNCCN Journal of the National Comprehensive Cancer Network, 16(7), 852-871. https://doi.org/10.6004/jnccn.2018.0060

Anal Carcinoma, version 2.2018 clinical practice guidelines in Oncology. / Benson, Al B.; Venook, Alan P.; Al-Hawary, Mahmoud M.; Cederquist, Lynette; Chen, Yi Jen; Ciombor, Kristen K.; Cohen, Stacey; Cooper, Harry S.; Deming, Dustin; Engstrom, Paul F.; Grem, Jean L; Grothey, Axel; Hochster, Howard S.; Hoffe, Sarah; Hunt, Steven; Kamel, Ahmed; Kirilcuk, Natalie; Krishnamurthi, Smitha; Messersmith, Wells A.; Meyerhardt, Jeffrey; Mulcahy, Mary F.; Murphy, James D.; Nurkin, Steven; Saltz, Leonard; Sharma, Sunil; Shibata, David; Skibber, John M.; Sofocleous, Constantinos T.; Stoffel, Elena M.; Stotsky-Himelfarb, Eden; Willett, Christopher G.; Wuthrick, Evan; Gregory, Kristina M.; Freedman-Cass, Deborah A.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 16, No. 7, 01.07.2018, p. 852-871.

Research output: Contribution to journalReview article

Benson, AB, Venook, AP, Al-Hawary, MM, Cederquist, L, Chen, YJ, Ciombor, KK, Cohen, S, Cooper, HS, Deming, D, Engstrom, PF, Grem, JL, Grothey, A, Hochster, HS, Hoffe, S, Hunt, S, Kamel, A, Kirilcuk, N, Krishnamurthi, S, Messersmith, WA, Meyerhardt, J, Mulcahy, MF, Murphy, JD, Nurkin, S, Saltz, L, Sharma, S, Shibata, D, Skibber, JM, Sofocleous, CT, Stoffel, EM, Stotsky-Himelfarb, E, Willett, CG, Wuthrick, E, Gregory, KM & Freedman-Cass, DA 2018, 'Anal Carcinoma, version 2.2018 clinical practice guidelines in Oncology', JNCCN Journal of the National Comprehensive Cancer Network, vol. 16, no. 7, pp. 852-871. https://doi.org/10.6004/jnccn.2018.0060
Benson, Al B. ; Venook, Alan P. ; Al-Hawary, Mahmoud M. ; Cederquist, Lynette ; Chen, Yi Jen ; Ciombor, Kristen K. ; Cohen, Stacey ; Cooper, Harry S. ; Deming, Dustin ; Engstrom, Paul F. ; Grem, Jean L ; Grothey, Axel ; Hochster, Howard S. ; Hoffe, Sarah ; Hunt, Steven ; Kamel, Ahmed ; Kirilcuk, Natalie ; Krishnamurthi, Smitha ; Messersmith, Wells A. ; Meyerhardt, Jeffrey ; Mulcahy, Mary F. ; Murphy, James D. ; Nurkin, Steven ; Saltz, Leonard ; Sharma, Sunil ; Shibata, David ; Skibber, John M. ; Sofocleous, Constantinos T. ; Stoffel, Elena M. ; Stotsky-Himelfarb, Eden ; Willett, Christopher G. ; Wuthrick, Evan ; Gregory, Kristina M. ; Freedman-Cass, Deborah A. / Anal Carcinoma, version 2.2018 clinical practice guidelines in Oncology. In: JNCCN Journal of the National Comprehensive Cancer Network. 2018 ; Vol. 16, No. 7. pp. 852-871.
@article{a0313407688a4ef4968b362fdef36362,
title = "Anal Carcinoma, version 2.2018 clinical practice guidelines in Oncology",
abstract = "The NCCN Guidelines for Anal Carcinoma provide recommendations for the management of patients with squamous cell carcinoma of the anal canal or perianal region. Primary treatment of anal cancer usually includes chemoradiation, although certain lesions can be treated with margin-negative local excision alone. Disease surveillance is recommended for all patients with anal carcinoma because additional curative-intent treatment is possible. A multidisciplinary approach including physicians from gastroenterology, medical oncology, surgical oncology, radiation oncology, and radiology is essential for optimal patient care.",
author = "Benson, {Al B.} and Venook, {Alan P.} and Al-Hawary, {Mahmoud M.} and Lynette Cederquist and Chen, {Yi Jen} and Ciombor, {Kristen K.} and Stacey Cohen and Cooper, {Harry S.} and Dustin Deming and Engstrom, {Paul F.} and Grem, {Jean L} and Axel Grothey and Hochster, {Howard S.} and Sarah Hoffe and Steven Hunt and Ahmed Kamel and Natalie Kirilcuk and Smitha Krishnamurthi and Messersmith, {Wells A.} and Jeffrey Meyerhardt and Mulcahy, {Mary F.} and Murphy, {James D.} and Steven Nurkin and Leonard Saltz and Sunil Sharma and David Shibata and Skibber, {John M.} and Sofocleous, {Constantinos T.} and Stoffel, {Elena M.} and Eden Stotsky-Himelfarb and Willett, {Christopher G.} and Evan Wuthrick and Gregory, {Kristina M.} and Freedman-Cass, {Deborah A.}",
year = "2018",
month = "7",
day = "1",
doi = "10.6004/jnccn.2018.0060",
language = "English (US)",
volume = "16",
pages = "852--871",
journal = "JNCCN Journal of the National Comprehensive Cancer Network",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "7",

}

TY - JOUR

T1 - Anal Carcinoma, version 2.2018 clinical practice guidelines in Oncology

AU - Benson, Al B.

AU - Venook, Alan P.

AU - Al-Hawary, Mahmoud M.

AU - Cederquist, Lynette

AU - Chen, Yi Jen

AU - Ciombor, Kristen K.

AU - Cohen, Stacey

AU - Cooper, Harry S.

AU - Deming, Dustin

AU - Engstrom, Paul F.

AU - Grem, Jean L

AU - Grothey, Axel

AU - Hochster, Howard S.

AU - Hoffe, Sarah

AU - Hunt, Steven

AU - Kamel, Ahmed

AU - Kirilcuk, Natalie

AU - Krishnamurthi, Smitha

AU - Messersmith, Wells A.

AU - Meyerhardt, Jeffrey

AU - Mulcahy, Mary F.

AU - Murphy, James D.

AU - Nurkin, Steven

AU - Saltz, Leonard

AU - Sharma, Sunil

AU - Shibata, David

AU - Skibber, John M.

AU - Sofocleous, Constantinos T.

AU - Stoffel, Elena M.

AU - Stotsky-Himelfarb, Eden

AU - Willett, Christopher G.

AU - Wuthrick, Evan

AU - Gregory, Kristina M.

AU - Freedman-Cass, Deborah A.

PY - 2018/7/1

Y1 - 2018/7/1

N2 - The NCCN Guidelines for Anal Carcinoma provide recommendations for the management of patients with squamous cell carcinoma of the anal canal or perianal region. Primary treatment of anal cancer usually includes chemoradiation, although certain lesions can be treated with margin-negative local excision alone. Disease surveillance is recommended for all patients with anal carcinoma because additional curative-intent treatment is possible. A multidisciplinary approach including physicians from gastroenterology, medical oncology, surgical oncology, radiation oncology, and radiology is essential for optimal patient care.

AB - The NCCN Guidelines for Anal Carcinoma provide recommendations for the management of patients with squamous cell carcinoma of the anal canal or perianal region. Primary treatment of anal cancer usually includes chemoradiation, although certain lesions can be treated with margin-negative local excision alone. Disease surveillance is recommended for all patients with anal carcinoma because additional curative-intent treatment is possible. A multidisciplinary approach including physicians from gastroenterology, medical oncology, surgical oncology, radiation oncology, and radiology is essential for optimal patient care.

UR - http://www.scopus.com/inward/record.url?scp=85049832554&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049832554&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2018.0060

DO - 10.6004/jnccn.2018.0060

M3 - Review article

C2 - 30006428

AN - SCOPUS:85049832554

VL - 16

SP - 852

EP - 871

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

SN - 1540-1405

IS - 7

ER -